Aveanna Names Matt Buckhalter CFO, Elevating Him From The Interim Tag

Aveanna Healthcare Holdings Inc. (Nasdaq: AVAH) has named Matt Buckhalter as its next CFO, elevating him from the interim tag he has held since June when David Afshar resigned from the role.

Buckhalter has been with the Atlanta-based company since 2016. Prior to the CFO role, he also served as SVP of finance and led the company’s investor relations group. His appointment becomes official on Jan. 1, and he will continue his role as principal financial officer.

“I am pleased to announce the promotion of Matt to the chief financial officer position,” Aveanna CEO Jeff Shaner said in a statement. “Matt has provided strong financial leadership and continuity as we build on our recent successes to transform our business. I have great confidence in the collaborative relationship between Matt, serving as our chief financial officer, and Deborah Stewart, continuing to serve in her role as our principal accounting officer. The leadership they bring to our accounting and finance teams, and Aveanna overall, is critical as we focus on executing our key initiatives into 2024.”


Aveanna provides pediatric care, home health care and hospice care to patients in 33 states. The company went public in 2021, transforming from strictly a pediatric care provider to a large home health and hospice enterprise through acquisition.

Since then, the company has experienced ups and downs, as well as significant turnover at the C-suite level. Buckhalter’s appointment favors continuity, and the provider has performed better on the public market toward the end of 2023.

“The board of directors is delighted with the appointment of Matt Buckhalter as Chief Financial Officer,” Aveanna Chairman Rod Windley said in a statement. “Having worked closely with Matt over the years, I have a high level of confidence with his financial acumen, industry knowledge, and health care expertise. The board recognizes this executive team’s ability to execute the Company’s vision and overall strategic initiatives to deliver high-quality care to our patients at an exceptional value to both our government and payer partners.”


In the third quarter, Aveanna posted revenues of $478 million, a 7.9% year-over-year increase. Its home health and hospice segment’s revenue totaled $53 million, a 6.3% year-over-year increase, while its private-duty segment brought in just short of $385 million, good for a 8.2% year-over year increase.

Companies featured in this article: